GH1 and hereditary endocrine growth disease: Similarly, in the management of growth disorders requiring GH treatment, effective monitoring of adherence can maximize the cost-effectiveness of treatment by optimizing growth outcomes such as final height and other clinical outcomes such as body composition, bone mineral density, cardiac function, lipid profile, and quality of life [7].